Identify the current therapies and endpoints
Compare functional and complete HBV cure
List virally targeted strategies to achieve these cures
Discuss decision making about candidacy for liver transplant
Discuss concepts about elderly patients with acute liver failure
Discuss the current status of liver allocation and its impact on liver transplantation in the Bay Area
Identify the challenges of matching donor with recipient
Discuss how sick is too sick for liver transplant
Explain new frameworks for predicting post-transplant outcomes and for discussing expectations from liver transplant and assessing patient preferences in high-risk surgical decision-making
Name the advantages of living donor transplant in pediatric patients
Identify strategies for increasing the priority of our patients awaiting liver transplant, in current system and with future policies
Discuss current research protocols offered at UCSF for treatment of chronbic Hepatitis C in children.
Discuss therapeutic options for chronic pancreatitis
Discuss the ECHO model
List the benefits to both patients and providers in rural areas
Name the advantages of living donor transplant for patients waitlisted for liver transplantation
Discuss how livers will be allocated
Discuss what’s next in liver allocation
Describe the role of liver transplantation for patients with HCC who are downstaged into conventional (Milan) transplant criteria
Identify the key predictors of HC recurrence post-LT, including modifiable factors such as pre-LT wait time
Discuss the rising incidence of intrahepatic cholangiocarcinoma
Explain clinical and biologic heterogeneity of cholangiocarcinoma
Discuss existing data on length of sobriety and its impact on post-transplant recidivism as well as the additional risk factors for post-transplant recidivism
Discuss the impact of post-transplant recidivism on patient outcomes
List the pros and cons of liver transplantation in patients with end stage alcoholic liver disease who have not completed 6 months of sobriety (the six-month rule)
Explore the relationship between beta blocker use and hepatic decompensation
Explain the concept of the “window” period for beta blocker use in cirrhotics
Explain the limitations of current therapy, especially in regards to emergence of resistance and impact on future treatment options
Describe how to maximize SVR rates in patients pre and post-LT through improved understanding of antiviral drug selection, management of drug-drug interaction and adherence
Explain what to expect from an ECHO hub and spoke
Evaluate treatment options for cholangiocarcinoma
Discuss the current literature and the pros and cons of liver transplantation for severe alcoholic hepatitis
What questions have arisen in your practice for which you need answers/strategies that you can implement?
Are you interested in basic, intermediate or advanced level trainings?
What barriers might you have that would interfere with implementation of new information learned from this training?
How can this training (the overall meeting) be improved to better impact competence, performance and/or patient/client outcomes?
Additional comments: